ACCESS AND AFFORDABILITY

FIRST-LINE BIOLOGIC ACCESS* IS AVAILABLE NATIONWIDE FOR

93%

OF MEDICARE
PART B PATIENTS1

93%

OF COMMERCIAL PATIENTS
WITHOUT A BIOLOGIC
STEP-EDIT1

SUPPORT FOR PATIENTS USING COMMERCIAL OR PRIVATE INSURANCE TO PAY FOR MEDICATION

Janssen CarePath Savings Program can help eligible patients save on their out-of-pocket medication costs for SIMPONI ARIA®.

Your eligible patients will pay $5 per infusion with a $20,000 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. Program does not cover the cost to give patients their treatments. See full eligibility requirements at SIMPONIARIA.JanssenCarePathSavings.com

Online enrollment and tracking of patient Savings Program benefits by you, the pharmacy, or the patient

Providers can enroll and help manage patients' Savings Program benefits with a Provider Portal Account at JanssenCarePathPortal.com

*First-line biologic: Brand-name drug that does not require trial on another biologic product prior to utilization.

Based on an analysis of major insurers that includes approximately 90% of commercially insured patients.

No biologic-step edit. Brand-name drug that does not require trial on another product prior to utilization.